vaccine
New Zealand’s PM signals harsher stance on vaccine protest-
By PTI WELLINGTON: New Zealand’s prime minister on Monday said protesters who oppose coronavirus mandates were using “intimidation and harassment,” ...
Biological E seeks EUA for its Corbevax vaccine for 12-18 yrs age group-
By PTI NEW DELHI: Biological E has sought emergency use authorisation from India’s drug regulator for its COVID-19 vaccine Corbevax ...
Kansas woman’s allergic reaction to Moderna coronavirus vaccine killed her, autopsy says
A Kansas woman’s death last March has been attributed to an allergic reaction to the Moderna coronavirus vaccine, an autopsy ...
SK Bioscience to develop COVID-19 Omicron-specific vaccine-
By ANI SEOUL [South Korea]: As the Omicron COVID-19 variant, which is now the most dominant strain in the world, rapidly ...
Novavax says protein vaccine works for kids as young as 12
Novavax announced Thursday that its COVID-19 vaccine proved safe and effective in a study of 12- to 17-year-olds.Novavax makes a ...
Indonesia starts testing homegrown Covid-19 vaccine on humans-
By AFP SURABAYA: Indonesia began testing a homegrown Covid-19 vaccine on humans Wednesday after getting the green light from the ...
Decision on third dose of COVID-19 vaccine for all adults will be based on scientific need: Government
The official said additional need for vaccination and inclusion of population for vaccination is examined constantly. Source link
Canadian provinces begin backing off vaccine mandates amid lingering Freedom Convoy protests
Some Canadian provinces announced they are rescinding their vaccine mandates as protesting Canadian truckers continue to block major arteries on ...
South Korea to roll out Novavax COVID-19 vaccine next week-
By Associated Press SEOUL: South Korea will begin offering Novavax Inc.’s COVID-19 vaccine at hospitals, nursing homes and public health ...
Vaccine sales push Pfizer earnings beyond expectations in final quarter-
By Associated Press WASHINGTON: COVID-19 vaccine sales boosted Pfizer earnings well past expectations in the fourth quarter, but the drugmaker ...
